Crystal Reynolds Email

Executive Assistant to the Partners . 1315 Capital

Current Roles

Employees:
22
Revenue:
$15M
About
1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty therapeutics companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$30 million investments in commercial healthcare entities that we believe have the potential to scale to approximately $100 million of revenue, a level we believe is highly attractive for acquisition or to access the public markets. In addition to experienced investing partners, 1315 Capital leverages an operating partner model of CEO and “Right Hand” COO Executive, a partnership that works together to navigate diligence, drive decisions, and seeks to achieve premium exits. Three operating teams contribute their collective experience to 1315 Capital in the areas of medical technologies, healthcare services, and specialty therapeutics. These three teams have built companies from expansion and growth phases to entities with revenues in excess of $100 million, resulting in almost $5 billion of aggregate exit value.
1315 Capital Address
2929 Walnut Street, Suite 1240
Philadelphia, PA
United States
1315 Capital Email

Past Companies

1315 CapitalExecutive Assistant to the Partners
Kayne Anderson Capital Advisors, L.P.Executive Assistant to Senior Managing Directors, Marketing/Investor Relations/Client Services
VelocifyExecutive Assistant to the COO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.